BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Meriç N, Albayrak E, Gülbaş Z, et al. (2023) MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis. Leukemia & Lymphoma. 1-12 |
| Yuce M, Albayrak E. (2023) Paracrine Factors Released from Tonsil-Derived Mesenchymal Stem Cells Inhibit Proliferation of Hematological Cancer Cells Under Hyperthermia in Co-culture Model. Applied Biochemistry and Biotechnology |
| Albayrak E, Kocabaş F. (2023) Therapeutic targeting and HSC proliferation by small molecules and biologicals. Advances in Protein Chemistry and Structural Biology. 135: 425-496 |
| Albayrak E, Akgol S, Turan RD, et al. (2022) BML-260 promotes the growth of cord blood and mobilized peripheral blood hematopoietic stem and progenitor cells with improved reconstitution ability. Journal of Cellular Biochemistry |
| Uslu M, Albayrak E, Kocabaş F. (2022) Competitive inhibition of IL-2/IL-2R has a dual effect on HSC ex vivo expansion and IL-2R (CD25) content. International Immunopharmacology. 110: 109035 |
| Albayrak E, Uslu M, Akgol S, et al. (2021) Small molecule-mediated modulation of ubiquitination and neddylation improves HSC function ex vivo. Journal of Cellular Physiology |
| Turan RD, Albayrak E, Uslu M, et al. (2020) Development of Small Molecule MEIS Inhibitors that modulate HSC activity. Scientific Reports. 10: 7994 |
| Uslu M, Albayrak E, Kocabaş F. (2020) Temporal modulation of calcium sensing in hematopoietic stem cells is crucial for proper stem cell expansion and engraftment. Journal of Cellular Physiology |
| Kabataş S, Civelek E, İnci Ç, et al. (2018) Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study. Cell Transplantation. 963689718786692 |
| Aksoz M, Albayrak E, Aslan GS, et al. (2018) c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression. Current Cancer Drug Targets |